FluoGuide A/S (FLUO.ST)

SEK 37.0

(-1.99%)

EBITDA Summary of FluoGuide A/S

FluoGuide A/S's latest annual EBITDA in 2023 was -43.9 Million DKK , down -35.44% from previous year.
FluoGuide A/S's latest quarterly EBITDA in 2024 Q2 was -7.98 Million DKK , up 3.49% from previous quarter.
FluoGuide A/S reported an annual EBITDA of -32.21 Million DKK in 2022, down -12.18% from previous year.
FluoGuide A/S reported an annual EBITDA of -28.65 Million DKK in 2021, down -31.25% from previous year.
FluoGuide A/S reported a quarterly EBITDA of -8.27 Million DKK for 2024 Q1, up 34.39% from previous quarter.
FluoGuide A/S reported a quarterly EBITDA of -10.8 Million DKK for 2023 Q3, down -25.77% from previous quarter.

Annual EBITDA Chart of FluoGuide A/S (2023 - 2018)

Historical Annual EBITDA of FluoGuide A/S (2023 - 2018)

Year	EBITDA	EBITDA Growth
2023	-43.9 Million DKK	-35.44%
2022	-32.21 Million DKK	-12.18%
2021	-28.65 Million DKK	-31.25%
2020	-22.04 Million DKK	-104.97%
2019	- DKK	-984409.62%
2018	- DKK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-7.98 Million DKK	3.49%
2024 Q1	-8.27 Million DKK	34.39%
2023 Q3	-10.8 Million DKK	-25.77%
2023 FY	- DKK	-35.44%
2023 Q4	-12.6 Million DKK	-16.75%
2023 Q2	-8.58 Million DKK	25.8%
2023 Q1	-11.57 Million DKK	-3.14%
2022 FY	- DKK	-12.18%
2022 Q3	-8.35 Million DKK	-11.98%
2022 Q2	-7.45 Million DKK	-38.37%
2022 Q1	-5.38 Million DKK	45.27%
2022 Q4	-11.22 Million DKK	-34.38%
2021 Q3	-8.89 Million DKK	-48.45%
2021 Q2	-5.99 Million DKK	-44.05%
2021 Q1	-4.16 Million DKK	51.08%
2021 FY	- DKK	-31.25%
2021 Q4	-9.84 Million DKK	-10.65%
2020 FY	- DKK	-104.97%
2020 Q4	-8.5 Million DKK	-172.37%
2020 Q3	-3.12 Million DKK	52.56%
2020 Q2	-6.58 Million DKK	-67.81%
2020 Q1	-3.92 Million DKK	-0.62%
2019 Q4	-3.89 Million DKK	22.9%
2019 Q3	-5.05 Million DKK	-276.26%
2019 Q2	-1.34 Million DKK	-204.07%
2019 Q1	-442 Thousand DKK	-44100.0%
2019 FY	- DKK	-984409.62%
2018 Q4	-1000.00 DKK	0.0%
2018 Q3	- DKK	0.0%
2018 FY	- DKK	0.0%
2018 Q2	- DKK	0.0%

Peer EBITDA Comparison of FluoGuide A/S

Name	EBITDA	EBITDA Difference
AddLife AB (publ)	1.54 Billion SEK	102.84%
Biotage AB (publ)	432 Million SEK	110.163%
Bonesupport Holding AB (publ)	28.93 Million SEK	251.719%
Doxa AB (publ)	296 Million SEK	114.832%
Elekta AB (publ)	3.29 Billion SEK	101.334%
iZafe Group AB (publ)	-15.61 Million SEK	-181.123%
Ortivus AB (publ)	-14.92 Million SEK	-194.138%
Ortivus AB (publ)	-14.92 Million SEK	-194.138%
Q-linea AB (publ)	-210.98 Million SEK	79.192%
S2Medical AB (publ)	-13.52 Million SEK	-224.507%
Synsam AB (publ)	1.71 Billion SEK	102.566%